 PIOMBINO DESE, Italy--BUSINESS WIRE--Stevanato Group S.p.A. NYSE: STVN, a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the KeyBanc Capital Markets Life Sciences MedTech Investor Forum. Management will present virtually at 9:00 a.m. EDT on Tuesday, March 22, 2022. A live audio webcast will be available on the Companys website at 